The sinusoidal obstructive syndrome (SOS) is a complication that usually follows hematopoietic stem cell transplantation. It is also known as veno-occlusive disease, which is a rare complication of living donor liver transplantation (LDLT). Herein, we reported a 34 year-old female patient presenting SOS after LDLT. Its underlying cause was presumed to be associated with liver abscess and subsequent inferior vena cava stenosis. SOS led to graft failure, thus requiring retransplantation with a deceased donor liver graft. The underlying causes of SOS are complex pathologic entity with multifactorial etiology. It is likely that its multifactorial etiology includes a decrease of hepatic venous outflow that is caused by graft liver infection and inferior vena cava stenosis. 
INTRODUCTION
Sinusoidal obstructive syndrome (SOS) was initially called veno-occlusive disease, 1 based on the triad of jaundice/hyperbilirubinemia (＞2 mg/dl), painful hepatomegaly and ascites/weight gain. It is confirmed by the histologic findings of fibrous obliteration of small hepatic veins by connective tissue and centrilobular hemorrhagic necrosis. 2 The most frequent cause of SOS is the use of high-dose chemotherapy in recipients of hematopoietic stem cell transplantation. [3] [4] [5] SOS is also described after liver transplantation (LT), but with relatively rare occurrence of approximately 2%. 6 Severe SOS leads to mortality rates of 84-90%. 7, 8 Development of SOS after LT is reportedly associated with tacrolimus administration. 9 Herein, we de- Thereafter, the patient condition was stabilized.
Repeat CT scan at POD24 revealed biloma around the liver graft (Fig. 1A) . The laboratory profiles showed decrease in total bilirubin to 1.6 m/dl, but increase in C-reactive protein (CRP) to 129 mg/dl. Abdominal drainage culture was Escherichia coli-positive; therefore, antibiotic was changed to Meropenem. Thereafter, CRP decreased Doppler ultrasonography showed significant decrease in RHV flow rate to 13 cm/sec after IVC stenting; and CT scan 9 days after stenting showed non-enhancement of the liver parenchyma (Fig. 1D) . The patient's condition con- 
DISCUSSION
SOS is characterized by toxic injury of sinusoidal endothelial cell, which is revealed as loss of sinusoidal wall.
SOS is occasionally associated with perisinusoidal fibrosis, centrilobular hepatic vein fibrotic obstruction, nodular regenerative hyperplasia, and peliosos. 10 The incidence of clinical SOS after LT is reported to be 1.9-2.9%. 11, 12 The clinical signs and symptoms are non-specific after LT, which results in difficult and complicated diagnosis. Developing SOS after LT reportedly correlates with acute cellular rejection. 5 An in vitro study
showed that toxins and drugs that cause hepatic SOS are more toxic to the hepatic sinusoidal endothelial cells than to the hepatocytes. 13, 14 Our present case was diagnosed based on explant pathology after retransplantation. The precedent underlying cause of SOS was possibly graft liver abscess and subsequent IVC stenosis. This case was not associated with any episode of acute rejection and we could exclude other potential pathology as well as infectious complication.
Moreover, the explant liver pathology showed 25% macrovesicular steatosis. A specific polymorphism of the glutathione-S-transferase gene is found more frequently among patients with SOS. 15 Thrombotic microangiopathy associated with significantly reduced survival following the allogeneic hematopoetic stem cell transplantation is another risk factor for development of transplantationassociated SOS. 16 Also, evidence of clotting abnormalities in the experimental model of hepatic SOS is lacking. 17 In particular, cytomegalovirus infection mediated vascular injury, results in incidence of hepatic artery thrombosis after LT. This injury occurs in the sinusoidal endothelium, which increases the risk of SOS development.
Positive expression of cytomegalovirus infection was absent in our case.
Tacrolimus is primarily metabolized by the cytochrome P450 (CYP) 3A subfamily in liver microsomes. The zone 3 of the liver acinus has the highest levels of CYP and is the most affected by SOS. 18 Hence, we considered Tacrolimus a potential factor for development of SOS after LT in our case. However, its 24-hour trough level was maintained between 10-16 ng/ml, which suggested no association with SOS development.
In conclusion, the underlying causes of SOS are a complex pathologic entity with multifactorial etiology. Its multifactorial etiologies are likely to include a decrease of hepatic venous outflow that is caused by graft liver infection and IVC stenosis.
